A randomised, double-blinded parallel group study to compare efficacy and tolerability of topically applied Baceca and Tazarotene against placebo and Tazarotene in patients with basal cell carcinoma.
Phase of Trial: Phase II
Latest Information Update: 08 Nov 2012
At a glance
- Drugs Valproic acid (Primary) ; Tazarotene
- Indications Basal cell cancer
- Focus Therapeutic Use
- Sponsors TopoTarget
- 29 Nov 2007 Status changed to completed.
- 29 Nov 2007 Results have been reported.
- 13 Nov 2007 New trial record.